Categories
Treatment of diabetes

Managing Blood Sugar Levels with Honey: Diabetics’ Guide

The Glycemic Index (GI) and Its Impact on Blood Sugar

The glycemic index (GI) indicates how quickly carbohydrates are converted into glucose. Foods with a high GI lead to a rapid increase in blood sugar levels, while those with a low GI cause a slower rise.

Honey’s GI and Its Effects on Blood Sugar

Although honey, a natural sweetener made of glucose and fructose, has a higher GI than table sugar, it may have a lesser impact on blood sugar levels.

Factors Affecting Honey’s GI

Factors Affecting Honey's GI

The GI of honey varies depending on the type, processing, and quantity consumed. Generally, lighter honeys and raw honey tend to have lower GIs.

Benefits of Honey for Diabetics

Benefits of Honey for Diabetics

Despite having a higher GI, honey provides antioxidants and may assist in controlling blood sugar levels. Certain types, such as Manuka and buckwheat honey, have lower GIs.

Precautions for Diabetic Honey Consumption

  • Regularly monitor blood sugar levels.
  • Opt for honey with a lower GI.
  • Use honey moderately to prevent sudden spikes in blood sugar.

Including Honey Safely in a Diabetic Diet

Choosing honey with a lower GI and consuming it in moderation can be advantageous. Honey can be a substitute for refined sugar in various recipes.

Health Benefits and Precautions of Honey Consumption

While honey may offer health benefits like allergy relief and a reduced risk of heart disease, it is crucial to use it sparingly due to its sugar content.

About Honey and Glycemic Index

Honey, a natural sweetener with a lower GI than table sugar, could be a healthier option for individuals with diabetes. Studies suggest that honey causes smaller spikes in blood sugar compared to other sweeteners.

Honey, being sweeter than white sugar, leads to a lesser increase in blood sugar levels after consumption. Research indicates that honey can enhance insulin production and sensitivity, potentially reducing blood sugar in people with diabetes. While the GI of a food is important, how the body metabolizes it also relies on the meal context. The polyphenols in honey assist in balancing gut bacteria and reducing inflammation, benefiting heart health.

Health benefits of honey

Darker honey contains higher levels of polyphenols and may improve blood fat levels, lowering the risk of heart disease. Local raw honey might alleviate symptoms of allergic rhinitis. Further research is required as there are limited long-term studies on honey consumption.

Importance of eating in moderation

Honey is a preferable choice over white sugar for individuals with diabetes, although it still raises blood sugar levels. Ensure that the honey is 100% pure to avoid added sweeteners. A well-rounded diet comprising protein, healthy fats, and fiber-rich carbohydrates is crucial for managing blood sugar levels.

Consider collaborating with a health coach to create a personalized plan for effective blood sugar management. Receive real-time glucose readings, medication guidance, nutritional advice, and fitness support for improved health outcomes.

This article is accessible to all and distributed under the Creative Commons Attribution License.

Abstract

Abstract

Recent studies suggest that honey could serve as a potential antidiabetic agent, offering benefits for diabetes management and its associated complications.

1. Introduction

Diabetes, a metabolic disorder with various causes, impacts millions globally. The medicinal properties of honey may aid in managing diabetes alongside conventional medical treatments.

There has been a misconception regarding the suitability of honey in the diet of individuals with diabetes due to its high carbohydrate content. A review of numerous literature studies aims to address whether honey can be a viable sugar substitute in a diabetic diet. Research indicates the possible effects of honey on diabetes.
The fructose content in honey varies, with studies suggesting a hypoglycemic effect. Fructose may reduce blood glucose levels in individuals with diabetes through mechanisms such as decreased absorption rates and stimulation of liver functions.
Studies have explored the effects of fructose on glycemic control and body weight. In animal models such as rats, fructose has demonstrated the ability to enhance glucose regulation and insulin response, indicating potential advantages.
Animal models, including rats induced with streptozotocin and alloxan, have been utilized to study honey’s hypoglycemic effects. Research on rats fed diets containing honey has shown encouraging results in weight management and improved cholesterol levels.
In both healthy rats and those induced with diabetes, honey has exhibited a hypoglycemic effect. It has also enhanced the antihyperglycemic properties of standard antidiabetic medications, suggesting its potential as a treatment for diabetes.
Overall, preclinical studies on animal models support the positive impact of honey on diabetes mellitus. Further research is required to comprehensively understand its mechanisms and potential therapeutic applications.

Reference Experimentation on Animals Therapy Outcomes
[10] A total of 60 rats with diabetes were split into 6 groups and received different substances Administered unique treatments orally daily for a period of 4 weeks The diverse treatments resulted in different impacts on the levels of blood glucose
[11] Rats with diabetes induced by streptozotocin (STZ) Received different amounts of honey by mouth for a period of 4 weeks The use of honey led to better antioxidant levels and lower lipid peroxidation in the treated rats
[12] Male rats with diabetes were administered Tualang honey to lower liver enzyme levels The addition of honey demonstrated protective effects on the liver
[14]
Rats were divided into different groups and received various treatments
The rats that were given honey showed a reduction in their blood glucose levels
Improvements in cholesterol levels and liver function tests were noted
[33] A study involving 8 groups of rats with diabetes Administered various oral treatments once daily for a period of 4 weeks The combination of metformin and glibenclamide with honey demonstrated beneficial effects on the renal function [47] Rats with and without diabetes Gave Tualang honey to diabetic rats by mouth Using honey led to lower blood sugar levels in diabetic rats [65] Comparison of glucose levels in normal and diabetic rabbits Administration of honey orally with different dosages No significant impact of honey on blood sugar levels in rabbits [66] Various groups of male Wistar rats Given honey and other compounds for a period of 3 weeks The diabetic rats showed decreased blood sugar levels after consuming honey [67] In a study involving six-week-old rats and various diets The group of rats that consumed a diet with honey exhibited negative impacts on HbA1c levels Elevated triglyceride levels were observed in rats with high sugar intake
[68] Male rats in adulthood who were fed different diets Rats that consumed honey showed reduced weight gain and increased levels of HDL The intake of honey had a beneficial effect on the rats’ cholesterol levels
[71] The study involved rats separated into diabetic and non-diabetic categories The rats were administered various treatments to evaluate how they impacted blood sugar levels Results showed that honey had hypoglycemic properties and enhanced antioxidant functions

Importance of a Well-Balanced Diet

It is essential for human beings to consume all the necessary nutrients such as water, proteins, lipids, carbohydrates, vitamins, minerals, amino acids, and bioactive compounds to support life. Maintaining a healthy and balanced diet is vital for overall well-being. Any imbalances in metabolism, whether from a lack or an excess of nutrients, can result in various health problems.

One such health issue is diabetes, which is characterized by high blood sugar levels due to insufficient insulin production. Research on animals indicates that including honey in the diet can aid in managing diabetes and its complications. Limited studies on humans, both healthy individuals and those with diabetes, have shown beneficial effects of consuming honey.

Al-Waili’s research highlighted that adding honey to the diets of healthy individuals, diabetes patients, and those with hypertriglyceridemia led to improved lipid profiles, reduced inflammation markers, and better control of blood sugar levels. In comparison to refined sugar, honey resulted in lower spikes in blood sugar.

Unlike sugar, which is a highly processed product mainly composed of sucrose and widely utilized in the food industry, honey is a natural sweetener with a complex composition. It has a lower glycemic index and energy value than sugar. The chemical makeup of honey can vary based on its botanical and geographical origins.

A table comparing the chemical composition of honey to sugar is provided in Table 2. Honey contains fewer calories, less sugar, and higher levels of essential nutrients like vitamins and minerals in comparison to sugar.

Comparison of Honey and Sugar Composition

Check out the chemical composition differences between honey and sugar here.

Nutrient/100 g Honey ∗ Sugar
Glycemic index 58 60
Calories 300 Kcal 387 Kcal
Sugars 80.0 g 99.9 g
Lipids 0.02 g
Protein 0.3 g
Calcium 6.0 mg 1.0 mg
Iron 0.42 mg 0.01 mg
Magnesium 2.0 mg
Phosphorus 4.0 mg
Zinc 0.22 mg
Potassium 52.0 mg 2.0 mg
Vitamin C 0.5 mg


Research on the Effects of Honey on Blood Sugar Levels

※ The data on honey values are based on averages from various honey varieties.

Honey has a unique composition with high fructose content, which could potentially have a positive impact on blood sugar levels. Fructose promotes the absorption and storage of glucose in the liver, aiding in the control of blood glucose levels.

An encouraging clinical study involving twenty individuals with type 2 diabetes who replaced their medication with honey showcased promising outcomes in managing the condition, as detailed in Table 3.

Exploring the Effects of Honey on Individuals with Diabetes

Reference Studies Teams Treatment Plans with Honey/Sugars Achieved Outcomes
[16] 17 participants in the control group
38 participants in the experimental group
During the study, the control group consumed 70g of sucrose daily for 30 days, while the experimental group consumed 70g of honey. The consumption of honey resulted in a slight decrease in body weight (1.3%) and body fat (1.1%), as well as reductions in total cholesterol (3%), LDL-C (5.8), triacylglycerol (11%), FBG (4.2%), and CRP (3.2%), with an increase in HDL-C (3.3%) among healthy individuals. Patients experienced reductions in total cholesterol by 3.3%, LDL-C by 4.3%, triacylglycerol by 19%, and CRP by 3.3% due to honey consumption.
[31]
Study on 48 patients with type II diabetes:
Experimental group with honey
Control group
The experimental group consumed honey at a dose of 1 g/kg BW/day for the first 2 weeks, followed by 1.5 g/kg BW/day for the next 2 weeks, then 2 g/kg BW/day for the subsequent 2 weeks, and finally 2.5 g/kg BW/day for the last 2 weeks
The honey group showed significant reductions in body weight, total cholesterol, LDL-C, and triglycerides, as well as a significant increase in HDL-C. Additionally, levels of hemoglobin A1C significantly increased in the honey group.
[36]
24 individuals in good health, 16 individuals with type II diabetes
6 individuals with high blood pressure
12 healthy participants underwent inhalation therapy with distilled water for 10 minutes initially; a week later, they were given a honey solution (60% wt/v) for the same duration. Another group of 12 healthy individuals received inhalation therapy with 10% dextrose for 10 minutes.
The inhalation of honey resulted in a significant decrease in random blood glucose levels from 199+/−40.9 mg/dl to 156+/−52.3 mg/dl after 30 minutes. Fasting blood glucose levels remained lower for up to 3 hours post-inhalation. During the glucose tolerance test, the intensity of hyperglycemia was significantly reduced following honey inhalation.
[54] Study involving 32 individuals with type II diabetes (non-insulin dependent) Participants were given a diet containing different carbohydrates: 25 g of glucose, fructose, or lactose, or 30 g of honey, 50 g of white bread, 125 g of white rice or potatoes, and 150 g of apples or 260 g of carrots. Blood glucose and plasma insulin levels were measured before and after the meal at intervals of 15, 30, 60, 90, and 120 minutes. When the blood glucose increase after consuming glucose was considered as 100%, the increases for other carbohydrates were as follows: fructose, 81.3%; lactose, 68.6%; apples, 46.9%; potatoes, 41.4%; bread, 36.3%; rice, 33.8%; honey, 32.4%; and carrots, 16.1%. [73] The study included 20 young individuals with type I diabetes in the experimental group, and 10 healthy non-diabetics in the control group The prescribed quantity of glucose, sucrose, and honey was calculated based on the subject’s weight (kg) multiplied by 1.75, with a maximum of 75 g per patient. In both the patient and control groups, honey exhibited a lower Glycemic Index and Postprandial Insulin Increment compared to sucrose. In the patient group, there was no significant rise in C-peptide levels following honey consumption as opposed to glucose or sucrose.
[76] Study participants included 30 individuals who had a parent with type II diabetes. Two groups were given either glucose or honey diet supplementation. Results showed that plasma glucose levels peaked at 30–60 minutes after consuming honey, then decreased rapidly compared to glucose. Subjects with diabetes demonstrated high tolerance to honey, indicating a lower glycemic index compared to glucose.
[78]
Study participants: 48 individuals, including those who were healthy, diabetic, and had hyperlipidemia
  1. Choice between a dextrose solution (250 ml water with 75 g dextrose) or honey solution (250 ml water with 75 g natural honey)
  2. Option of dextrose, honey, or artificial honey (250 ml water with 35 g dextrose and 40 g fructose)
  3. Administration of honey solution for a 15-day period
  4. Choosing between honey or artificial honey
  5. Consumption of either 70 g dextrose or 90 g honey for patients with type 2 diabetes mellitus
  6. Consumption of 30 g sucrose or 30 g honey for diabetic patients
Findings:

  • Healthy subjects showed that dextrose increased PGL levels at 1 and 2 hours but decreased after 3 hours. Honey, on the other hand, elevated PGL levels after 1 hour and then decreased after 3 hours. Insulin and C-peptide levels were significantly higher after dextrose consumption compared to honey. Dextrose led to a slight reduction in cholesterol and LDL-C levels after 1 hour, which became significant after 2 hours, and an increase in TG levels after 1, 2, and 3 hours. Artificial honey showed a slight decrease in cholesterol and LDL-C levels while increasing TG levels. Honey consumption led to reductions in cholesterol, LDL-C, and TG levels and a slight increase in HDL-C levels. After 15 days of honey consumption, cholesterol, LDL-C, TG, CRP, homocysteine, and PGL levels decreased, while HDL-C levels increased.
  • Hypertriglyceridemic patients experienced an increase in TG levels with artificial honey consumption, but a decrease with honey. Patients with hyperlipidemia saw an increase in LDL-C levels with artificial honey and a decrease with honey. After 15 days of honey consumption, there were reductions in cholesterol, LDL-C, and CRP levels.
  • In diabetic patients, honey resulted in a significantly lower rise in PGL levels compared to dextrose. The rise in PGL levels was higher with honey than with sucrose at 30 minutes, but lower at other intervals. Honey led to increased insulin levels compared to sucrose at different intervals, and lower PGL rises in diabetic individuals.
[80] A group of 20 adult patients with type 2 diabetes and related metabolic issues, aged between 30 and 65 years, participated in the study, including both men and women. The prescribed amount of honey was 2 grams per kilogram of body weight per day. This was administered by dissolving 50 ml (60 g) of honey in water at a 1:3 ratio and giving it to the patients twice a day before meals. The remaining 25 ml (30 g) was used for sweetening purposes. The consumption of honey led to increased levels of blood sugar in these patients, although they did not experience diabetic ketoacidosis (DKA) or hyperglycemic hyperosmolar state (HHS). Over time, the patients who consumed honey also experienced weight loss, and those with hypertension saw improvements in their blood pressure. Patients with pre-existing coronary heart disease (CHD) showed better cardiovascular health following the honey intervention.
[88] 50 individuals diagnosed with type I diabetes
30 individuals without diabetes
Dosage of honey: 1.75 grams per kilogram of body weight
Dosage of sucrose: 1.75 grams of sugar per kilogram of body weight
The Glycemic Index (GI) and Postprandial Insulinemic Index (PII) levels of sucrose and honey showed no significant differences between the diabetic patients and the control group. However, both the GI and PII levels of honey were notably lower compared to sucrose in both the patients and controls. Moreover, in both the diabetic patients and controls, there was a significant increase in C-peptide levels after honey consumption, compared to glucose or sucrose.

In addition to the glycemic index (GI), peak incremental index (PII) is utilized to evaluate the glycemic impact of various foods on blood glucose levels [81].
C-peptide is recognized as a reliable indicator of insulin secretion, co-secreted with insulin as a by-product of pancreatic cells without any biological activity of its own [82], resulting from the enzymatic breakdown of proinsulin into insulin. Studies examining the effects of honey on insulin and C-peptide levels in both healthy and diabetic individuals have yielded conflicting results [54, 83, 84].
A study conducted at the National Institute of Diabetes in Cairo, Egypt, involving twenty diabetic youths and ten non-diabetic individuals aimed to clarify this discrepancy [73]. Glucose, sucrose, and honey solutions were diluted in 200 ml of water based on the participant’s weight (amount of sugar/honey = subject’s weight in kg × 1.75, with a maximum of 75 g). Each participant ingested the diluted sugars and honey in the morning, one week apart for each type, with the entire testing period lasting three weeks. Blood samples were collected before consumption and at 30-minute intervals after ingestion until 120 minutes (2 hours). The serum C-peptide level and blood glucose levels were analyzed in all samples.
Both the patients and the control group exhibited lower glycemic index and peak incremental index values when honey was consumed compared to glucose and fructose, although the C-peptide levels differed between the two groups.
The consumption of honey may have a positive impact on plasma C-peptide levels in non-diabetic individuals, promoting the activation of pancreatic beta cells [73]. Despite a lower GI compared to sugar (Table 2), the GI of honey varies depending on the fructose/glucose ratio [85, 86]. Different varieties of honey have shown varying effects on glucose levels in different studies [85]. Honey consumption has been associated with weight loss and improved blood glucose control in both healthy individuals and diabetics when compared to sugar [31]. Research suggests that honey can contribute to hypoglycemic effects [12, 33]. Additionally, honey has shown potential in managing diabetic wounds, aiding in the healing process due to its antioxidant and antimicrobial properties [75, 92–93].
Numerous studies worldwide have demonstrated the effectiveness of honey in treating diabetic wounds, reducing pain, and accelerating the healing process [100–105]. Specifically, Manuka honey has shown promising results in wound healing [106]. Guidelines recommend the use of natural, unheated honey stored in dark glass containers for wound treatments [99]. Experimental studies have indicated the potential benefits of honey in diabetes management, including controlling blood glucose levels and reducing metabolic disorders [107]. However, further research, involving larger sample sizes and longer durations, is essential to confirm its efficacy in diabetes management.
1. Ionescu-Târgovişte C., Popa E., Sintu E., Mihalache N., Cheta D., Mincu I. Blood sugar reactions to different types of carbohydrates in individuals with non-insulin-dependent diabetes. Published in Diabetologia in 1983;24(2):80–84.
2. Sunehag A. L., Toffolo G., Campioni M., Bier D. M., Haymond M. W. Consumption of high levels of fructose in the diet does not impact insulin sensitivity, glucose levels, or lipid metabolism in obese teenagers. Research found in the Journal of Pediatric Endocrinology and Metabolism in 2008;21(3):225–235.
3. Ngo Sock E. T., Le K. A., Ith M., Kreis R., Boesch C., Tappy L. A short-term increase in fructose or glucose consumption in young males. This study was published in the British Journal of Nutrition in 2009;103(07):939–943.
4. Bocarsly M. E., Powell E. S., Avena N. M., Hoebel B. G. Obesity-like symptoms induced by high-fructose corn syrup in rats. Published in Pharmacology, Biochemistry, and Behavior in 2010;97(1):101–106.
5. Dolan L. C., Potter S. M., Burdock G. A. The impact of regular fructose consumption on blood lipids and weight in overweight individuals. Written up in Critical Reviews in Food Science and Nutrition in 2010;50(10):889–918.
6. Madero M., Arriaga J. C., Jalal D., et al. A comparison of two energy-restricted diets, one low in fructose and the other containing moderate natural fructose, on weight loss and metabolic syndrome. Study featured in Metabolism Clinical and Experimental in 2011;60(11):1551–1559.
7. Malik V. S., Schulze M. B., Hu F. B. A systematic review on the connection between intake of sugar-sweetened beverages and weight gain. Found in The American Journal of Clinical Nutrition in 2006;84(2):274–288.
8. Jentjens R. L., Underwood K., Achten J., Currell K., Mann C. H., Jeukendrup A. E. Analysis of exogenous carbohydrate oxidation rates following combined intake of glucose and fructose during exercise in hot conditions. Published in the Journal of Applied Physiology in 2006;100(3):807–816.
9. Prieto P. G., Cancelas J., Villanueva-Peñacarrillo M. L., Valverde I. Examining glucose, fructose, and insulin reactions in rats following oral administration. Research published in the Journal of the American College of Nutrition in 2004;23(5):414–419.
10. Srinivasan K., Viswanad B., Asrrat L., Kaul C. L., Ramaro P. Using a high-fat diet and low-dose streptozotocin to create a rat model for type 2 diabetes. Featuring study in Pharmacological Research in 2005;52(4):313–320.
11. Lenzen S. Understanding the mechanisms behind alloxan- and streptozotocin-induced diabetes. Presented in Diabetologia in 2008;51(2):216–226.
12. Akhtar M. S., Khan M. S. Responses of blood sugar to various types of honey in normal and diabetic rabbits. Featured in the Journal of Pakistan Medical Association in 1989;39(4):107–113.
13. Fasanmade A. A., Alabi O. T. Different effects of honey seen in diabetic rats. Presented in the African Journal of Biomedical Research in 2008;11(20):191–196.
14. Chepulis L. M. Contrasting effects of honey, sucrose, and a sugar-free diet on weight gain in rats. Study found in the Journal of Food Science in 2007;72(3):S224–S229.
15. Chepulis L., Starkey N. Long-term impact of honey consumption on weight gain, lipid profiles, and measurements in rats. Research reported in the Journal of Food Science in 2008;73(1):H1–H7.
16. Busseroles J., Gueux E., Rock E. Honey defending rats from the hypertriglyceridemic and prooxidative consequences of fructose. Published in The Journal of Nutrition in 2002;132:3379–3382.
17. Nemoseck T. M., Carmody E. G., Furchner-Evanson A. Research has shown that honey leads to lower weight gain, adiposity, and triglycerides compared to sucrose in rats. Featured in Nutrition Research in 2011;31(1):55–60. doi: 10.1016/j. nutres.2010.11.002.
18. Erejuwa O. O., Sulaiman S. A., Wahab M. S., Sirajudeen K. N. S., Salzihan M. S. Examining the effects of Malaysian Tualang honey supplementation on blood sugar levels, antioxidant enzymes, and markers of oxidative stress in the kidneys of both normal and streptozotocin-induced diabetic rats. Featured in the International Journal of Cardiology in 2009;137, article S45 doi: 10.1016/j. ijcard.2009.09.148.
19. Ahmad A., Azim M. K., Mesaik M. A., Khan R. A. Comparing the glycemic response of natural honey to simulated honey and D-glucose. Study found in the Journal of Food Science in 2008;73(7):H165–H167. doi: 10.1111/j.1750-3841.2008.00887.x.
20. Abdulrahman M., El-Hefnawy M., Hussein R., El-Goud A. A. Measuring glycemic and peak incremental indices of honey, sucrose, and glucose in patients with type 1 diabetes mellitus and assessing their effects on C-peptide levels in a pilot study. Published in Acta Diabetologica in 2011;48(2):89–94.

  • 97. Al-Waili N. S., Saleeb N. Honey increased nitric oxide and product in saliva of healthy volunteers. FASEB Conference; 2003; San Diego. pp. 11–15. [Google Scholar]
  • 98. Molan P. C. The role of honey in the management of wounds. Journal of Wound Care. 1999;8(8):415–418. doi: 10.12968/jowc.1999.8.8.25904. [DOI] [PubMed] [Google Scholar]
  • 99. Molan P. C. Re-introducing honey in the management of wounds and ulcers-theory and practice. Ostomy/Wound Management. 2002;48(11):28–40. [PubMed] [Google Scholar]
  • 100. Kamaratos A. V., Tzirogiannis K. N., Iraklianou S. A., Panoutsopoulos G. I., Kanellos I. E., Melidonis A. I. Manuka honey-impregnated dressings in the treatment of neuropathic diabetic foot ulcers. International Wound Journal. 2014;11(3):259–263. doi: 10.1111/j.1742-481X.2012.01082.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101. Shukrimi A., Sulaiman A. R., Halim A. Y., Azril A. A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers. Medical Journal of Malaysia. 2008;63(1):44–46. [PubMed] [Google Scholar]
  • 102. Alzahrami H. A., Bakhotmah B. A., Boukraa L. In vitro susceptibility of diabetic wound bacteria to mixture of honey, Commiphora molmol and Nigella sativa. The Open Nutraceuticals Journal. 2011;4:172–175. doi: 10.2174/1876396001104010172. [DOI] [Google Scholar]
  • 103. Al Saeed M. Therapeutic efficacy of conventional treatment combined with Manuka honey in the treatment of patients with diabetic foot ulcers: a randomized controlled study. The Egyptian Journal of Hospital Medicine. 2013;53:1064–1071. doi: 10.12816/0001668. [DOI] [Google Scholar]
  • 104. Lotfy M., Badra G., Burham V., Alenzi F. Q. Combined used of honey, bee propolis and myrth in healing a deep, infected wound in a patient with diabetes mellitus. British Journal of Medical Science. 2006;63(4):171–173. doi: 10.1080/09674845.2006.11732742. [DOI] [PubMed] [Google Scholar]
  • 105. Meo S. A., Al-Asiri S. A., Mahesar A. L., Ansari M. J. Role of honey in modern medicine. Saudi Journal of Biological Sciences. 2017;24(5):975–978. doi: 10.1016/j. sjbs.2016.12.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106. Alvarez-Suarez J. M., Giampieri F., Cordero M., et al. Activation of AMPK/Nrf2 signalling by Manuka honey protects human dermal fibroblasts against oxidative damage by improving antioxidant response and mitochondrial function promoting wound healing. Journal of Functional Foods. 2016;25:38–49. doi: 10.1016/j. jff.2016.05.008. [DOI] [Google Scholar]

The deliberation on the connection between honey and diabetes mellitus, concentrating on hindrances and predicaments in the path to advancement. The investigation was released in the Saudi Journal of Biological Sciences in 2017. The researchers include Meo S. A., Ansari M. J., Sattar K., Ullah C. H., Hajjar W., and Alasiri S. The paper is available at DOI: 10.1016/j. sjbs.2016.12.020.

To explore additional articles, please go to Oxidative Medicine and Cellular Longevity, a periodical by Wiley.